Condition: Chronic Myelomonocytic Leukemia · Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
This study is a randomized, controlled, double-blind, multicenter, phase Ⅲ clinical study to evaluate the efficacy of IMM01(timdarpacept) in combination with azacitidine versus placebo in combination with azacitidine in patients with newly diagnosed chronic leukemia monocytic (CMML1-2).Primary endpoint are Complete remission rate and Overall survival.
This description comes directly from the study's public registry record.
Yujuan Ma · 86-15021694761 · yujuan.ma@immuneonco.com
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | Recruiting |
| China-Japan Friendship Hospita | Beijing, Beijing Municipality, China | Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| First Hospital of Lanzhou University | Lanzhou, Gansu, China | Not Yet Recruiting |
| The First Affiliated Hospital of Guangxi Medical University | Nanning, Gaungxi, China | Recruiting |
| Nanfang Hospital, Southern Medical University | Guangzhou, Guangdong, China | Recruiting |
| Shenzhen Second People's Hospital | Shenzhen, Guangdong, China | Not Yet Recruiting |
| Zhujiang Hospital of Southern Medical University | Zhujiang, Guangdong, China | Not Yet Recruiting |
| Guangdong Provincial People's Hospital | Guangzhou, Guangzhou, China | Recruiting |
| Affiliated Hospital of Guizhou Medical University | Guiyang, Guizhou, China | Recruiting |
| Affiliated Hospital of Hebei University | Shijiazhuang, Hebei, China | Not Yet Recruiting |
| The Second Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Not Yet Recruiting |
+ 31 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06647862